Skip to main navigation Skip to search Skip to main content

Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice

  • Halina Offner
  • , Kirsten Adlard
  • , Bruce F. Bebo
  • , Jeanette Schuster
  • , Gregory G. Burrows
  • , Abigail C. Buenafe
  • , Arthur A. Vandenbark

Research output: Contribution to journal › Article › peer-review

Abstract

TCR determinants overexpressed by autopathogenic Th1 cells can naturally induce a second set of TCR-specific regulatory T cells. We addressed the question of whether immune regulation could be induced naturally in a genetically restricted model in which a major portion of TCR-specific regulatory T cells expressed the same target TCR BV8S2 chain as the pathogenic T cells specific for myelin basic protein (MBP). We found vigorous T cell responses to BV8S2 determinants in naive mice that could be further potentiated by vaccination with heterologous BV8S2 proteins, resulting in the selective inhibition of MBP-specific Th1 cells and protection against experimental encephalomyelitis. Moreover, coculture with BV8S2-specific T cells or their supernatants reduced proliferation, IFN-γ/secretion, and encephalitogenic activity of MBP-specific T cells. These results suggest that immune regulation occurs through a nondeletional cytokine-driven suppressive mechanism.

Original languageEnglish (US)
Pages (from-to)2178-2186
Number of pages9
JournalJournal of Immunology
Volume161
Issue number5
StatePublished - Sep 1 1998

Funding

Experimental Autoimmune Encephalomyelitis in Chemokine Receptor Deficient Mice D. Pitt~ Albert Ein,s tein College of Medicine, USA, W.A. Kuziel, Universityo f Texas, USA, P. Charles, B. Cannella, C.S. Paine, AlbertEinstein College of Medicine, USA Monocyte chemoattractant protein-I (MCP-1), a member of the chemokine family, is implicated in experimental autoimmune encephalomyelitis (EAE) in the directing of lymphocytes and monocytes to CNS lesions. However, the precise role of MCP-I and the consequences of long-term disruption of MCP-I signaling in EAE are not known. To address these issues, we have utilized mice lacking the receptor for MCP-I, CCR-2 \[Kuziel et al. 1997, PNAS 94, 12053\]. EAE was induced by active sensitization with myelin oligodandrocyte glycoprotein. In comparison with wild type C57BL/6 controls, CCR-2 4-mice showed a marked delay in the onset of EAE, a ditinctively milder clinical course and almost complete recovery from the initial acute disease. Histologic analysis revealed CNS lesions infiltrated almost exclusively by polymorphonuclear leukocytes with little or to monocytic component in agreement with previous studies in other conditions showing reduction in monocyte accumulation (Kuziel et. al., 1997). Thus, CCR2 deletion in murine EAE causes a dramatic shift in the composition of CNS-infiltrating cells and less severe lesions associated with a milder clinical outcome. (Supported by NMSS RG 1001-1-9; NS 08952 and NS 11920. DP is supported by the DFG, Germany)

FundersFunder number
NMSSNS 08952, NS 11920, RG 1001-1-9
National Institute of Neurological Disorders and StrokeR01NS023444
Deutsche Forschungsgemeinschaft

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology

    Fingerprint

    Dive into the research topics of 'Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice'. Together they form a unique fingerprint.

    Cite this